CAR-T Cell Therapy Demonstrates Encouraging Outcomes for Stiff Person Syndrome

A recent study published in JAMA Neurology indicates that a single infusion of modified CAR-T cells significantly improved mobility and reduced muscle stiffness in patients with stiff person syndrome. This research, while not yet a cure, presents a promising new therapeutic direction for the rare neurological autoimmune disorder. Further investigation is necessary to confirm long-term safety and effectiveness.